FDANonrulemakingFDA-2014-D-0779

Who commented on this docket

Draft Guidance for Industry on Current Good Manufacturing Practice — Interim Guidance for Human Drug Compounding Outsourcing Facilities under Section 503B of the FD&C Act; Availability

1 organizations filed 1 public comment on Draft Guidance for Industry on Current Good Manufacturing Practice — Interim Guidance for Human Drug Compounding Outsourcing Facilities under Section 503B of the FD&C Act; Availability, at the Food and Drug Administration. The comment window closed 2724d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2724d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Draft Guidance for Industry on Current Good Manufacturing Practice — Interim Guidance for Human Drug Compounding Outsourcing Facilities under Section 503B of the FD&C Act; Availability (FDA-2014-D-0779) | OpenPolis